Showing results (251-260 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|November 6, 2025
Spatiotemporal control of SMARCA5 by a MAPK-RUNX1 axis distinguishes mutant KRAS-driven pancreatic malignancy from tissue regenerationJing Han, Xiaoman Lu, Mengmeng Guo, et al.Nature Cancer|June 23, 2020
Long-distance modulation of bystander tumor cells by CD8+ T cell-secreted IFNγMirjam E Hoekstra, Laura Bornes, Feline E Dijkgraaf, et al.Nature Cancer|August 27, 2021
Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunityYingzhong Li, Zhijun Su, Weiyu Zhao, et al.Nature Cancer|August 9, 2021
Missing the target in cancer therapyJacob J Adashek, Alexey Goloubev, Shumei Kato, et al.Nature Cancer|June 23, 2025
Innate immunity and the NF-κB pathway control prostate stem cell plasticity, reprogramming and tumor initiationChen Jiang, Yura Song, Sandrine Rorive, et al.Nature Cancer|June 30, 2025
Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancerLaura Antonucci, Na Li, Angeles Duran, et al.Nature Cancer|June 30, 2025
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trialEdith Borcoman, Bastien Cabarrou, Miguel Francisco, et al.Nature Cancer|June 24, 2025
Concurrent inhibition of tumor growth and metastasis by a lipidated nanophotosensitizer tracing and disabling tumor extracellular vesiclesGuifeng Miao, Zhanhao Shang, Xinyue Wang, et al.Nature Cancer|December 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancersJiaxin Ge, Joshua Urban, Sarah R DiNapoli, et al.Nature Cancer|February 10, 2025
Targeting ADAR1 with a small molecule for the treatment of prostate cancerXiao Wang, Jiaxing Li, Yasheng Zhu, et al.Pageof 65